Rare diseases
Investigational molecules
Locations
211 conditions with trials, the busiest first
497 trials across Europe, recruiting first
Bioequivalence Study of Linagliptin 5 mg Film‑Coated Tablets in Healthy Volunteers for Diabetes Treatment
SpainRelative bioavailability and safety of elinzanetant soft‑gel capsules in healthy adults for vasomotor symptoms
GermanyA study to compare the absorption of testosterone transdermal gel in healthy female subjects
PortugalA study testing ALN-4324 for safety and effectiveness in overweight to obese patients with type 2 diabetes
GermanyStudy comparing cagrilintide and semaglutide versus tirzepatide in people with type 2 diabetes taking metformin or SGLT2 inhibitor
GermanyA study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin
BulgariaA study testing TRV045 for pain relief in healthy adults to understand its effects on nerve pain from diabetic peripheral neuropathy
The NetherlandsA study comparing how lenvatinib capsules are absorbed in the body in healthy volunteers under fasting and fed conditions
PortugalA study comparing weekly insulin icodec and semaglutide with daily insulin degludec and insulin aspart in people with type 2 diabetes not well controlled on premixed insulin
PolandA study testing cagrilintide and semaglutide compared to placebo in people with type 2 diabetes not well controlled by diet and exercise
HungaryA study testing cagrilintide and semaglutide compared to placebo in people with type 2 diabetes taking basal insulin with or without metformin
SlovakiaStudy comparing semaglutide and dapagliflozin taken separately or combined in one tablet for type 2 diabetes patients
GermanyThe therapies tested most often in Endocrine disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
